Combining in vivo cell-specific delivery technology with precision genetic medicines
Founded in 2025 in Massachusetts, Tiva Biosciences is a biotechnology company developing advanced delivery technologies to empower in vivo precision medicine.
Transforming Cell & Gene Therapy with Targeted Nanoparticle Technology
Our world-class team of scientists and engineers have established robust technology platforms including targeted Lipid NanoParticle (tLNP) formulation, conjugation and characterization. We have enabled multiple clients to achieve industry leading delivery efficiency and efficacy in animal models.
OUR Mission Provide best-in-class targeted LNP technical service and product for in vivo cell and gene therapy researchers.
OUR vision To lead the future of genetic medicine by pioneering next-generation targeted delivery platforms that enable in vivo cell and gene therapies, making transformative treatments a reality for patients everywhere.